Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare.
The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry.
Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.
Hospital workers begin unloading precious frozen vials of COVID-19 vaccine Monday, with the first vaccinations against a scourge that has killed nearly 300,000 Americans expected later in the day.
Sen. Tina Smith (D-Minn.) joined Cheddar to discuss the need for the federal government to provide more help to states in order to effectively distribute the COVID vaccines.
Get better sleep, improve productivity and boost overall happiness with a little help from these highly-rated mindfulness picks.
Airships were once believed to be the future of human flight, so why did they fall out of favor so quickly and which flaws ultimately made them a design disaster?
Over 24 million adults in the United States have eye issues: Either you’re born with eye issues, you grow up to have eye issues, or you get so old that your eyes deteriorate into one big issue. So why are our eyes an engineering nightmare? Cheddar explains.
Make a gamer's day with the hottest accessories, subscriptions and consoles of the holiday season.
A new report shows how warming temperatures in the Arctic are transforming the region's geography and ecosystems.
Indian health officials say they have found traces of nickel and lead in a few blood samples taken from hundreds of patients who have been hospitalized by a mysterious illness in a southern state.
British regulators warned Wednesday that people who have a history of serious allergic reactions shouldn’t receive the new Pfizer-BioNTech vaccine as they investigate two adverse reactions that occurred on the first day of the country’s mass vaccination program.
These seven surprises are guaranteed to top a gadget lover's holiday wish list.
